PDS Biotechnology Corporation
PDSB
$0.29
-$0.01-2.33%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 12.13M | 12.31M | 12.52M | 13.08M | 12.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.83M | 28.96M | 31.54M | 32.23M | 34.27M |
| Operating Income | -27.83M | -28.96M | -31.54M | -32.23M | -34.27M |
| Income Before Tax | -33.67M | -33.36M | -35.67M | -36.05M | -37.77M |
| Income Tax Expenses | 0.00 | 0.00 | -1.17M | -1.17M | -1.17M |
| Earnings from Continuing Operations | -33.67 | -33.36 | -34.50 | -34.89 | -36.60 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -33.67M | -33.36M | -34.50M | -34.89M | -36.60M |
| EBIT | -27.83M | -28.96M | -31.54M | -32.23M | -34.27M |
| EBITDA | -27.77M | -28.90M | -31.48M | -32.17M | -34.21M |
| EPS Basic | -0.65 | -0.68 | -0.75 | -0.82 | -0.92 |
| Normalized Basic EPS | -0.40 | -0.42 | -0.49 | -0.53 | -0.59 |
| EPS Diluted | -0.65 | -0.68 | -0.75 | -0.82 | -0.92 |
| Normalized Diluted EPS | -0.40 | -0.42 | -0.49 | -0.53 | -0.59 |
| Average Basic Shares Outstanding | 209.62M | 199.86M | 184.88M | 170.78M | 160.72M |
| Average Diluted Shares Outstanding | 209.62M | 199.86M | 184.88M | 170.78M | 160.72M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |